GTEX-XQ3S
|
21-40
|
Male
|
GTEX-XQ3S-2126 |
Liver
|
PAXgene |
2
|
2 pieces, 9x7 & 9x9mm; no steatosis
|
Acceptable
|
|
GTEX-XV7Q
|
41-50
|
Female
|
GTEX-XV7Q-1926 |
Liver
|
PAXgene |
3
|
2 pieces, 9x8 & 17.5x8mm; Marked midzonal necrosis, rep. areas delineated
|
Acceptable
|
|
GTEX-XXEK
|
51-60
|
Male
|
GTEX-XXEK-1126 |
Liver
|
PAXgene |
1
|
2 pieces, 8x8 & 8x7mm; mild mixed micro/macrovesicular steatosis, diffuse
|
Acceptable
|
|
GTEX-XYKS
|
61-70
|
Female
|
GTEX-XYKS-0326 |
Liver
|
PAXgene |
1
|
2 pieces, 8x7.5 & 9.5x9mm; cirrhosis with severe macrovesicular steatosis
|
Acceptable
|
|
GTEX-Y111
|
41-50
|
Male
|
GTEX-Y111-0726 |
Liver
|
PAXgene |
1
|
2 pieces, 9x8 & 10x8mm; 1 piece contains capsule
|
Acceptable
|
|
GTEX-Y3IK
|
51-60
|
Female
|
GTEX-Y3IK-0326 |
Liver
|
PAXgene |
1
|
2 pieces, 11x10 & 10x9mm. Moderate portal lymphoid infiltrates consistent with chronic hepatitis or chronic biliary tract disease. No steatosis.
|
Acceptable
|
|
GTEX-Y5LM
|
41-50
|
Female
|
GTEX-Y5LM-0426 |
Liver
|
PAXgene |
1
|
2 pieces. 13x9 & 13x10mm; 70% small droplet variant of macrovesicular steatosis.
|
Acceptable
|
|
GTEX-Y5V5
|
61-70
|
Female
|
GTEX-Y5V5-0926 |
Liver
|
PAXgene |
1
|
2 pieces, 10x10 & 11x10mm; mild-moderate macrovesicular steatosis involving ~30-40% of parenchyma
|
Acceptable
|
|
GTEX-YB5E
|
41-50
|
Male
|
GTEX-YB5E-0326 |
Liver
|
PAXgene |
1
|
2 pieces, 12x10 & 11x11mm; marked central and mid-zonal coagulative necrosis necrosis, shock vs toxic damage by drugs
|
Acceptable
|
|
GTEX-YEC4
|
21-40
|
Male
|
GTEX-YEC4-0826 |
Liver
|
PAXgene |
1
|
2 pieces, 12x5 and 10x8mm; diffuse macrovesciular steatosis involves ~80% of parenchyma
|
Acceptable
|
|
GTEX-YECK
|
61-70
|
Male
|
GTEX-YECK-1926 |
Liver
|
PAXgene |
2
|
2 pieces, 8x8 and 8x7mm;
|
Acceptable
|
|
GTEX-YFC4
|
41-50
|
Female
|
GTEX-YFC4-1526 |
Liver
|
PAXgene |
2
|
2 pieces, minimal steatosis, moderate autolysis
|
Acceptable
|
|
GTEX-YJ89
|
51-60
|
Male
|
GTEX-YJ89-1426 |
Liver
|
PAXgene |
1
|
2 pieces
|
Acceptable
|
|
GTEX-YJ8O
|
21-40
|
Female
|
GTEX-YJ8O-1726 |
Liver
|
PAXgene |
1
|
2 pieces, minimal steatosis, reasonably well-preserved
|
Acceptable
|
|
GTEX-Z93S
|
51-60
|
Male
|
GTEX-Z93S-0726 |
Liver
|
PAXgene |
2
|
2 pieces, diffuse macrovesicular steatosis involving ~60% of parenchyma
|
Acceptable
|
|
GTEX-Z9EW
|
41-50
|
Male
|
GTEX-Z9EW-0426 |
Liver
|
PAXgene |
1
|
2 pieces, diffuse macrovesicular steatosis involves ~ 50% of parenchyma
|
Acceptable
|
|
GTEX-ZAB4
|
41-50
|
Male
|
GTEX-ZAB4-0826 |
Liver
|
PAXgene |
2
|
2 pieces. Extensive central passive congestion and hemorrhage. Large vessels and stroma occupy 10% and 20%.
|
Acceptable
|
|
GTEX-ZAB5
|
51-60
|
Male
|
GTEX-ZAB5-0426 |
Liver
|
PAXgene |
0
|
2 pieces; diffuse macrovesicular steatosis involving about %60 of the liver parenchyma, few collections of chronic inflammatory cells
|
Acceptable
|
|
GTEX-ZAJG
|
51-60
|
Female
|
GTEX-ZAJG-1726 |
Liver
|
PAXgene |
3
|
2 pieces, badlyautolyzed
|
Acceptable
|
|
GTEX-ZAK1
|
51-60
|
Female
|
GTEX-ZAK1-1726 |
Liver
|
PAXgene |
1
|
2 pieces, some foci more autolyzed, approach score 2; minimal steatosis
|
Acceptable
|
|
GTEX-ZC5H
|
41-50
|
Female
|
GTEX-ZC5H-0726 |
Liver
|
PAXgene |
1
|
2 pieces, well preserved, moderate congestion, minimal steatosis
|
Acceptable
|
|
GTEX-ZDTS
|
61-70
|
Male
|
GTEX-ZDTS-1726 |
Liver
|
PAXgene |
1
|
2 pieces; no fat or inflammation
|
Acceptable
|
|
GTEX-ZDXO
|
51-60
|
Male
|
GTEX-ZDXO-2226 |
Liver
|
PAXgene |
2
|
2 pieces, minimal steatosis
|
Acceptable
|
|
GTEX-ZE7O
|
51-60
|
Female
|
GTEX-ZE7O-1226 |
Liver
|
PAXgene |
1
|
2 pieces; 50% macrovesicular steatosis
|
Acceptable
|
|
GTEX-ZE9C
|
61-70
|
Male
|
GTEX-ZE9C-1626 |
Liver
|
PAXgene |
2
|
2 pieces, moderate congestion; minimal steatosis
|
Acceptable
|
|